Medical Condition News

RSS

EBV exposure linked to life-threatening cancer risk in kidney transplant patients

More than 90% of the adult population in the U.S. is or has been infected with Epstein Barr virus (EBV). EBV is a highly contagious member of the herpes virus family, best known for causing infectious mononucleosis ("mono") and for its association with several cancers and autoimmune diseases.

10 Feb 2025

GUK1 enzyme plays crucial role in lung cancer metabolism and growth

Lung cancer is a particularly challenging form of cancer. It often strikes unexpectedly and aggressively with little warning, and it can shapeshift in unpredictable ways to evade treatment.

10 Feb 2025

E64FC26 inhibits inflammation and joint destruction in rheumatoid arthritis models

Protein disulfide isomerases (PDIs) are essential enzymes that facilitate the proper folding of proteins and maintain protein quality within the endoplasmic reticulum.

10 Feb 2025

New minimally invasive treatment offers hope for primary aldosteronism

Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of a simple, minimally invasive Targeted Thermal Therapy (Triple T) that has the potential to transform medical management of a common, but commonly overlooked, cause of high blood pressure.

10 Feb 2025

Exploring how outdoor activities can help young cancer survivors

There are not many programmes designed for young people living with or surviving cancer. UiA and the Hospital of Southern Norway, in collaboration with international researchers, aim to explore how outdoor activities and time in nature can enhance health and quality of life.

10 Feb 2025

Study uncovers potential target for treating keloid scars

Keloids are fibrotic scars that extend beyond the boundaries of the original wound, often causing physical disfigurement and emotional distress.

10 Feb 2025

Research highlights gender and age differences in eye gene therapy responses

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found.

10 Feb 2025

Novel MSC-based therapy provides hope for ocular GVHD treatment

Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the donor's immune cells attack the recipient's tissues.

10 Feb 2025

Pain may lead to increased cigarette and cannabis use in cancer survivors

Experiencing pain may increase the odds that cancer survivors will use cigarettes and cannabis, according to a recent study published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

10 Feb 2025

New biomarker test detects early tau tangles in Alzheimer's disease

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the University of Pittsburgh School of Medicine can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms that litter the brain, cerebrospinal fluid and potentially blood, new research published today in Nature Medicine suggests.

10 Feb 2025

Study reveals link between traumatic experiences and endometriosis risk

The study finds a connection between trauma and endometriosis, suggesting that addressing psychological factors could improve diagnosis and treatment outcomes.

10 Feb 2025

Microplastics in food packaging may increase heart disease risk

Microplastics pose a threat to heart health, causing harmful changes in vascular cells and increasing the risk of cardiovascular diseases like atherosclerosis.

10 Feb 2025

Tamworth’s Marianne Gaul honored with 2024 MS Advocate Award

Tamworth's Marianne Gaul AM, an acclaimed nurse and dedicated volunteer, has been awarded the 2024 MS Advocate Award by MS Australia.

10 Feb 2025

Professor Jeannette Lechner-Scott wins 2024 MS Research Award

Newcastle's Professor Jeannette Lechner-Scott, an internationally recognized neurologist and leader in multiple sclerosis (MS) research and clinical care, has been awarded the 2024 MS Research Award by MS Australia.

10 Feb 2025

Bunbury local Lynda Whitton awarded MS Australia’s highest honor

Bunbury local Lynda Whitton, a dedicated champion for people living with multiple sclerosis (MS), has been awarded MS Australia's highest honor, the 2024 John Studdy Award.

10 Feb 2025

Ariceum Therapeutics receives FDA’s Orphan Drug Designation for targeted radionuclide cancer treatment

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to 225Ac-SSO110 (satoreotide) for the treatment of patients with Small Cell Lung Cancer (SCLC).

10 Feb 2025